サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1326558

がん支持療法薬の世界市場規模調査＆予測、タイプ別、用途別、流通チャネル別、地域別分析、2023-2030年

Global Cancer Supportive Care Drugs Market Size study & Forecast, by Type by Application, by Distribution Channel and Regional Analysis, 2023-2030
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
がん支持療法薬の世界市場規模調査＆予測、タイプ別、用途別、流通チャネル別、地域別分析、2023-2030年
出版日: 2023年07月28日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

がん支持療法薬の世界市場は、2022年に約205億米ドルと評価され、予測期間2023-2030年には2.2％以上の健全な成長率で成長すると予測されています。

がん支持療法薬は、緩和ケア薬としても知られ、がんとその治療による症状や副作用を管理するために使用される薬剤です。これらの薬剤は、痛みを和らげ、治療に関連する合併症を軽減し、罹患中に生じる様々な身体的・精神的課題に対処することで、がん患者の生活の質を向上させるように設計されています。がん支持療法薬市場は、がんの有病率の上昇や医薬品開発に対する政府資金の増加などの要因により拡大しています。

国際がん研究機関（IARC）の推計によると、世界のがん罹患数の増加は、2021年の190万人から2040年には 2,750万人になると推定されています。さらに、可処分所得の増加やヘルスケア構造の改善も、人々ががん支持療法薬を利用するのに役立っており、これも市場の成長を後押ししています。例えば、2021年8月の最新情報によると、シンガポールのMediShield Lifeの保険料は、使用する薬剤に応じて月額3,000米ドルから200米ドルから9,600米ドルの範囲になっています。また、一部の高価な薬に対する薬物治療支援基金の補助金の受給資格を2,800米ドルから6,500米ドルに引き上げるとともに、政府はより多くのがん治療にも補助金を支給します。さらに、がん支持療法薬の研究開発およびパイプラインの増加、世界の老人人口の急増が、この市場に有利な成長をもたらしています。しかし、がん支持療法薬のコストが高いことが、2023-2030年の予測期間を通じて市場の成長を阻害しています。

がん支持療法薬の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、主要市場プレイヤーの優位性、同地域におけるがん疾患の罹患率の上昇、同地域における新がん治療薬の市場開拓の高まりにより、2022年の市場を独占しました。アジア太平洋地域は、がんの罹患率の上昇、研究開発活動への資金提供や投資の増加、業界への政府支援の増加などの要因により、予測期間中に最も速い速度で成長すると予想されます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や市場情勢の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

  • 市場スナップショット
  • 世界の市場推計・予測（セグメント別）、2020年～2030年
  • 主要動向
  • 推計手法
  • 調査前提条件

第2章 世界のがん支持療法薬市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 業界の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 がん支持療法薬の世界市場力学

  • がん支持療法薬市場の影響分析（2020年～2030年）
    • 市場促進要因
      • がん罹患率の増加
      • 医薬品開発に対する政府資金の増加
    • 市場の課題
      • がん支持療法薬の高コスト
    • 市場機会
      • がん支持療法薬の研究開発およびパイプライン数の増加
      • 世界の高齢者人口の急増

第4章 がん支持療法薬の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 がん支持療法薬の世界市場：タイプ別

  • 市場スナップショット
  • がん支持療法薬の世界市場：タイプ別、実績 - ポテンシャル分析
  • がん支持療法薬の世界市場：タイプ別推定・予測：2020-2030年
  • がん支持療法薬の世界市場、サブセグメント別分析
    • ESA（赤血球造血刺激因子製剤）
    • ESA（赤血球造血刺激因子製剤）
    • G-CSF（顆粒球コロニー刺激因子）
    • 制吐剤
    • ビスフォスフォネート
    • オピオイド
    • NSAIDs（非ステロイド性自己炎症薬）
    • その他

第6章 がん支持療法薬の世界市場：用途別

  • 市場スナップショット
  • がん支持療法薬の世界市場：用途別、実績 - ポテンシャル分析
  • がん支持療法薬の世界市場：用途別推定・予測2020～2030年
  • がん支持療法薬の世界市場、サブセグメント別分析
    • 乳がん
    • 肺がん
    • 大腸がん
    • 前立腺がん
    • 肝臓がん
    • 胃がん
    • その他

第7章 がん支持療法薬の世界市場：流通チャネル別

  • 市場スナップショット
  • がん支持療法薬の世界市場：流通チャネル別、実績 - ポテンシャル分析
  • がん支持療法薬の世界市場：流通チャネル別推定・予測2020～2030年
  • がん支持療法薬の世界市場、サブセグメント別分析
    • 病院薬局
    • ドラッグストアおよび小売薬局
    • オンラインプロバイダー

第8章 がん支持療法薬の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • がん支持療法薬の世界市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別推定・予測、2020-2030年
      • 用途の推定・予測、2020-2030年
      • 流通チャネルの推定・予測、2020-2030年
    • カナダ
  • 欧州がん支持療法薬市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋がん支持療法薬市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカのがん支持療法薬市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他中東とアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Amgen Inc.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 最近の動向
    • Baxter International Inc.
    • F Hoffmann-La Roche Ltd.
    • Glaxosmithkline Plc（Gsk）（Tesasro）
    • Heron Therapeutics Inc
    • Johnson & Johnson（Janssen Global Services, Llc,）
    • Merck Kgaa
    • Novartis International Ag（Sandoz）
    • Teva Pharmaceuticals Industries Ltd
    • Helsinn Healthcare SA

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Cancer Supportive Care Drugs Market, report scope
  • TABLE 2. Global Cancer Supportive Care Drugs Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Cancer Supportive Care Drugs Market estimates & forecasts by Type 2020-2030 (USD Billion)
  • TABLE 4. Global Cancer Supportive Care Drugs Market estimates & forecasts by Application 2020-2030 (USD Billion)
  • TABLE 5. Global Cancer Supportive Care Drugs Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Cancer Supportive Care Drugs Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Cancer Supportive Care Drugs Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Cancer Supportive Care Drugs Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Cancer Supportive Care Drugs Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Cancer Supportive Care Drugs Market
  • TABLE 71. List of primary sources, used in the study of global Cancer Supportive Care Drugs Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Cancer Supportive Care Drugs Market, research methodology
  • FIG 2. Global Cancer Supportive Care Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Cancer Supportive Care Drugs Market, key trends 2022
  • FIG 5. Global Cancer Supportive Care Drugs Market, growth prospects 2023-2030
  • FIG 6. Global Cancer Supportive Care Drugs Market, porters 5 force model
  • FIG 7. Global Cancer Supportive Care Drugs Market, pest analysis
  • FIG 8. Global Cancer Supportive Care Drugs Market, value chain analysis
  • FIG 9. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Cancer Supportive Care Drugs Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Cancer Supportive Care Drugs Market, regional snapshot 2020 & 2030
  • FIG 15. North America Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Cancer Supportive Care Drugs Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Cancer Supportive Care Drugs Market is valued at approximately USD 20.50 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 2.2% over the forecast period 2023-2030. Cancer supportive care drugs, also known as palliative care drugs, are medications used to manage the symptoms and side effects of cancer and its treatments. These drugs are designed to improve the quality of life for cancer patients by alleviating pain, reducing treatment-related complications, and addressing various physical and emotional challenges that arise during the disease. The Cancer Supportive Care Drugs Market is expanding because of factors such as the rising prevalence of cancer, and rising government funding for drug development.

The rising prevalence of cancer globally is fostering market growth, according to estimates from the International Agency for Research on Cancer (IARC), The estimated increase in the worldwide burden of cancer is 27.5 million new cases by 2040 from 1.9 million new cases in year 2021.Furthermore, increasing disposable income as well as improved healthcare structure has also helped people to access cancer supportive care drugs, which is also helping this market grow. For instance, according to an update from August 2021, MediShield Life coverage in Singapore went from paying USD 3,000 per month to a range of USD 200 to USD 9,600 per month, depending on the medications used. Along with increasing the eligibility requirements for Medication Assistance Fund subsidies for some expensive medications from USD 2,800 to USD 6,500, the government would also subsidize more cancer treatments. In addition, the increase in R&D and several pipeline cancer supportive care drugs and the surge in the global geriatric population are creating lucrative growth in the market. However, the high cost of Cancer Supportive Care Drugs stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Cancer Supportive Care Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the dominance of key market player, rising prevelance of cancer disease in the region, and rising development of new cancer drugs in the region. Asia Pacific is expected to grow at a fastest rate during the forecast period, owing to factors such as rising prevelance of cancer, rising funding and investment on research and development activities and rising government support to the industry.

Major market player included in this report are:

  • Amgen Inc.
  • Baxter International Inc.
  • F Hoffmann-La Roche Ltd.
  • Glaxosmithkline Plc (Gsk) (Tesasro)
  • Heron Therapeutics Inc
  • Johnson & Johnson (Janssen Global Services, Llc,)
  • Merck Kgaa
  • Novartis International Ag (Sandoz)
  • Teva Pharmaceuticals Industries Ltd
  • Helsinn Healthcare SA

Recent Developments in the Market:

  • In March 2022, Australian-based Imugene announced a new clinical trial partnership and supply agreement with MSD, a brand name of Merck & Co., Inc., Kenilworth, NJ, USA, to test the safety and effectiveness of Imugene's HER-Vaxx, a B-cell activating immunotherapy, in combination with MSD's anti-PD-1 therapy, pembrolizumab (KEYTRUDA), in patients with HER-2 positive gastric cancer.
  • In March 2022, Pluvicto from Novartis has been authorised by the US Food and Drug Administration (FDA) to treat people with this specific cancer type. These patients have already had androgen receptor pathway inhibition and taxane-based chemotherapy.

Global Cancer Supportive Care Drugs Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Type, Application, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Type offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • ESA (Erythropoiesis-Stimulating Agents)
  • G-CSFs (Granulocyte Colony-Stimulating Factors)
  • Antiemetics
  • Bisphosphonates
  • Opioids
  • NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
  • Others

By Application:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Liver Cancer
  • Stomach Cancer
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Cancer Supportive Care Drugs Market, by Region, 2020-2030 (USD Billion)
    • 1.2.2. Cancer Supportive Care Drugs Market, by Type, 2020-2030 (USD Billion)
    • 1.2.3. Cancer Supportive Care Drugs Market, by Application, 2020-2030 (USD Billion)
    • 1.2.4. Cancer Supportive Care Drugs Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Cancer Supportive Care Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Cancer Supportive Care Drugs Market Dynamics

  • 3.1. Cancer Supportive Care Drugs Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of cancer
      • 3.1.1.2. Rising government funding for drugs development
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Cancer Supportive Care Drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Increase in R&D and number of pipeline cancer supportive care drugs
      • 3.1.3.2. Surge in global geriatric population

Chapter 4. Global Cancer Supportive Care Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Cancer Supportive Care Drugs Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Cancer Supportive Care Drugs Market by Type, Performance - Potential Analysis
  • 5.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
  • 5.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
    • 5.4.1. ESA (Erythropoiesis-Stimulating Agents)
    • 5.4.2. ESA (Erythropoiesis-Stimulating Agents)
    • 5.4.3. G-CSFs (Granulocyte Colony-Stimulating Factors)
    • 5.4.4. Antiemetics
    • 5.4.5. Bisphosphonates
    • 5.4.6. Opioids
    • 5.4.7. NSAIDs (Non-Steroidal Auto Inflammatory Drugs)
    • 5.4.8. Others
    • 5.4.9.

Chapter 6. Global Cancer Supportive Care Drugs Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Cancer Supportive Care Drugs Market by Application, Performance - Potential Analysis
  • 6.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
  • 6.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
    • 6.4.1. Breast Cancer
    • 6.4.2. Lung Cancer
    • 6.4.3. Colorectal Cancer
    • 6.4.4. Prostate Cancer
    • 6.4.5. Liver Cancer
    • 6.4.6. Stomach Cancer
    • 6.4.7. Others

Chapter 7. Global Cancer Supportive Care Drugs Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Cancer Supportive Care Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Cancer Supportive Care Drugs Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Cancer Supportive Care Drugs Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacies
    • 7.4.2. Drug Stores and Retail Pharmacies
    • 7.4.3. Online Providers

Chapter 8. Global Cancer Supportive Care Drugs Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Cancer Supportive Care Drugs Market, Regional Market Snapshot
  • 8.4. North America Cancer Supportive Care Drugs Market
    • 8.4.1. U.S. Cancer Supportive Care Drugs Market
      • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Cancer Supportive Care Drugs Market
  • 8.5. Europe Cancer Supportive Care Drugs Market Snapshot
    • 8.5.1. U.K. Cancer Supportive Care Drugs Market
    • 8.5.2. Germany Cancer Supportive Care Drugs Market
    • 8.5.3. France Cancer Supportive Care Drugs Market
    • 8.5.4. Spain Cancer Supportive Care Drugs Market
    • 8.5.5. Italy Cancer Supportive Care Drugs Market
    • 8.5.6. Rest of Europe Cancer Supportive Care Drugs Market
  • 8.6. Asia-Pacific Cancer Supportive Care Drugs Market Snapshot
    • 8.6.1. China Cancer Supportive Care Drugs Market
    • 8.6.2. India Cancer Supportive Care Drugs Market
    • 8.6.3. Japan Cancer Supportive Care Drugs Market
    • 8.6.4. Australia Cancer Supportive Care Drugs Market
    • 8.6.5. South Korea Cancer Supportive Care Drugs Market
    • 8.6.6. Rest of Asia Pacific Cancer Supportive Care Drugs Market
  • 8.7. Latin America Cancer Supportive Care Drugs Market Snapshot
    • 8.7.1. Brazil Cancer Supportive Care Drugs Market
    • 8.7.2. Mexico Cancer Supportive Care Drugs Market
  • 8.8. Middle East & Africa Cancer Supportive Care Drugs Market
    • 8.8.1. Saudi Arabia Cancer Supportive Care Drugs Market
    • 8.8.2. South Africa Cancer Supportive Care Drugs Market
    • 8.8.3. Rest of Middle East & Africa Cancer Supportive Care Drugs Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Amgen Inc.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Baxter International Inc.
    • 9.3.3. F Hoffmann-La Roche Ltd.
    • 9.3.4. Glaxosmithkline Plc (Gsk) (Tesasro)
    • 9.3.5. Heron Therapeutics Inc
    • 9.3.6. Johnson & Johnson (Janssen Global Services, Llc,)
    • 9.3.7. Merck Kgaa
    • 9.3.8. Novartis International Ag (Sandoz)
    • 9.3.9. Teva Pharmaceuticals Industries Ltd
    • 9.3.10. Helsinn Healthcare SA

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption